<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=LP-211</id>
	<title>LP-211 - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=LP-211"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=LP-211&amp;action=history"/>
	<updated>2026-04-08T20:17:23Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=LP-211&amp;diff=5809736&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=LP-211&amp;diff=5809736&amp;oldid=prev"/>
		<updated>2024-05-22T18:06:40Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:LP-211_structure.png|thumb|LP-211_structure.png]] &amp;#039;&amp;#039;&amp;#039;LP-211&amp;#039;&amp;#039;&amp;#039; is a synthetic compound that acts as a selective agonist for the [[5-HT7 receptor]]. It has been primarily used in scientific research to investigate the role of the 5-HT7 receptor in various physiological and neurological processes.&lt;br /&gt;
&lt;br /&gt;
==Chemical Properties==&lt;br /&gt;
LP-211 is a member of the class of compounds known as [[tryptamines]]. It has a molecular formula of C_20H_21N_3O and a molecular weight of 319.40 g/mol. The compound is characterized by its high affinity and selectivity for the 5-HT7 receptor, making it a valuable tool in neuropharmacological studies.&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
The primary action of LP-211 is its agonistic effect on the 5-HT7 receptor, a subtype of the [[serotonin receptor]] family. The 5-HT7 receptor is involved in the regulation of various neurological processes, including [[circadian rhythm]], [[mood]], and [[cognition]]. Activation of this receptor by LP-211 has been shown to influence these processes, making it a subject of interest in the study of [[neuropsychiatric disorders]] such as [[depression]], [[anxiety]], and [[schizophrenia]].&lt;br /&gt;
&lt;br /&gt;
==Research Applications==&lt;br /&gt;
LP-211 has been utilized in various preclinical studies to explore the therapeutic potential of 5-HT7 receptor modulation. Research has indicated that LP-211 may have potential benefits in the treatment of [[sleep disorders]], [[cognitive dysfunction]], and [[mood disorders]]. Additionally, studies have investigated its role in [[neuroplasticity]] and [[neuroprotection]], suggesting that LP-211 could be beneficial in conditions such as [[Alzheimer&amp;#039;s disease]] and [[Parkinson&amp;#039;s disease]].&lt;br /&gt;
&lt;br /&gt;
==Safety and Toxicology==&lt;br /&gt;
As with many research chemicals, the safety profile of LP-211 is not fully established. Preliminary studies suggest that it has a relatively low toxicity, but comprehensive toxicological data are lacking. Researchers using LP-211 are advised to follow standard safety protocols and conduct thorough risk assessments.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[5-HT7 receptor]]&lt;br /&gt;
* [[Serotonin receptor]]&lt;br /&gt;
* [[Neuropharmacology]]&lt;br /&gt;
* [[Tryptamine]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
{{Commons category|LP-211}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Serotonin receptor agonists]]&lt;br /&gt;
[[Category:Tryptamines]]&lt;br /&gt;
[[Category:Research chemicals]]&lt;br /&gt;
[[Category:Neuropharmacology]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>